<p class="MsoNormal">US biotechnology company Moderna announced its potential COVID-19 vaccine is 94.5% effective, making it the second coronavirus shot developed by an American drugmaker to show early encouraging results after the Pfizer-BioNTech vaccine. Moderna's stocks jumped on the news during premarket trading, soaring 15.94% to $103.64.</p>
